We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+3.47%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$46.8B
AUM Growth
+$254M
(+0.55%)
Cap. Flow
-$1.34B
Cap. Flow
% of AUM
-2.85%
Top 10 Holdings %
Top 10 Hldgs %
20.47%
Holding
1,215
New
187
Increased
315
Reduced
335
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$262M |
| 2 |
SHPG
Shire pic
SHPG
|
+$247M |
| 3 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$185M |
| 4 |
Aon
AON
|
+$176M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$162M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CFN
CAREFUSION CORPORATION
CFN
|
+$399M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$350M |
| 3 |
UnitedHealth
UNH
|
+$293M |
| 4 |
Zoetis
ZTS
|
+$252M |
| 5 |
Chevron
CVX
|
+$221M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.76% |
| 2 | Communication Services | 14.29% |
| 3 | Technology | 13.4% |
| 4 | Financials | 12.61% |
| 5 | Industrials | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Teva Pharmaceuticals
TEVA
$36.3B
| $1.1B | 2.34% |
19,057,219
+1,237,198
| +7% | +$68.9M |
|
2
Baidu
BIDU
$36.5B
| $1.07B | 2.3% |
4,715,349
-634,844
| -12% | -$146M |
|
|
CHL
3
DELISTED
China Mobile Limited
CHL
| $1.07B | 2.29% |
18,206,306
+76,782
| +0.4% | +$4.6M |
|
4
NetEase
NTES
$76.9B
| $982M | 2.1% |
49,518,490
-617,005
| -1% | -$11.8M |
|
5
Telkom Indonesia
TLK
$14.2B
| $977M | 2.09% |
43,188,244
+167,520
| +0.4% | +$3.8M |
|
6
Apple
AAPL
$4.72T
| $969M | 2.07% |
35,106,260
+142,788
| +0.4% | +$3.88M |
|
7
Cisco
CSCO
$444B
| $965M | 2.06% |
34,698,622
+5,075,938
| +17% | +$131M |
|
8
TSMC
TSM
$2.16T
| $906M | 1.93% |
40,476,959
+2,626,929
| +7% | +$57.2M |
|
9
Advance Auto Parts
AAP
$3.22B
| $785M | 1.68% |
4,930,610
-463,299
| -9% | -$68.1M |
|
|
VIAB
10
DELISTED
Viacom Inc. Class B
VIAB
| $761M | 1.62% |
10,107,015
+1,098,601
| +12% | +$80.3M |
|
|
EMC
11
DELISTED
EMC CORPORATION
EMC
| $728M | 1.56% |
24,490,580
+5,385,927
| +28% | +$157M |
|
|
12
Zoetis
ZTS
$31.3B
| $714M | 1.53% |
16,602,660
-6,220,829
| -27% | -$252M |
|
13
PLDT
PHI
$4.17B
| $667M | 1.42% |
10,536,164
+2,378
| +0% | +$158K |
|
14
Pfizer
PFE
$143B
| $645M | 1.38% |
21,822,425
-1,085,715
| -5% | -$31.1M |
|
15
Ambev
ABEV
$47.7B
| $593M | 1.27% |
95,353,342
+15,603,633
| +20% | +$98.5M |
|
16
Visa
V
$669B
| $561M | 1.2% |
8,555,412
-893,960
| -9% | -$53.8M |
|
17
Microsoft
MSFT
$2.83T
| $559M | 1.19% |
12,044,620
-731,556
| -6% | -$34.3M |
|
18
Alphabet (Google) Class C
GOOG
$3.89T
| $539M | 1.15% |
20,439,102
+3,476,900
| +20% | +$93.3M |
|
19
Honeywell
HON
$78B
| $522M | 1.11% |
5,812,455
+595,596
| +11% | +$51.2M |
|
20
Citigroup
C
$221B
| $492M | 1.05% |
9,100,155
-300,337
| -3% | -$15.9M |
|
21
Baxter International
BAX
$11.2B
| $477M | 1.02% |
11,977,001
+1,416,690
| +13% | +$55.2M |
|
22
Xerox
XRX
$341M
| $466M | 1% |
12,764,578
+1,877,056
| +17% | +$66.2M |
|
23
American Express
AXP
$233B
| $435M | 0.93% |
4,679,268
-111,951
| -2% | -$10M |
|
24
Sysco
SYY
$39.1B
| $426M | 0.91% |
10,722,498
+1,117,071
| +12% | +$43.3M |
|
25
Eli Lilly
LLY
$1.06T
| $390M | 0.83% |
5,647,213
-258,083
| -4% | -$17.4M |
|
Similar funds
QCM
Lazard Asset Management's Q4 2014 Portfolio in Review
As of Q4 2014, Lazard Asset Management held 1,215 positions worth $46.8B, up 0.55% from $46.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Lazard Asset Management's Q4 2014 filing shows 187 new, 315 increased, 335 reduced and 83 closed positions. Its largest new stake was NXP Semiconductors: 3,692,675 shares worth $282M. The largest sale was CAREFUSION CORPORATION, an estimated $399M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Communication Services and Technology.
- Lazard Asset Management's largest Q4 2014 buy was NXP Semiconductors: 3,692,675 shares worth $282M.
- Lazard Asset Management added most to Aon in Q4 2014, an estimated $176M increase.
- Lazard Asset Management's biggest Q4 2014 reduction was CAREFUSION CORPORATION, cutting an estimated $399M.
- Lazard Asset Management fully exited COVANCE INC. in Q4 2014, selling an estimated $99M.
- Lazard Asset Management's ten largest holdings make up 20% of its $46.8B portfolio in Q4 2014.
- Lazard Asset Management opened 187 new positions and closed 83 in Q4 2014.
- Lazard Asset Management's portfolio value rose 0.55% quarter-over-quarter to $46.8B.
Based on Lazard Asset Management's 13F filing for Q4 2014, filed 12 Feb 2015.